Bivariate Sequential Designs for Phase II Trials
From MaRDI portal
Publication:4855194
DOI10.2307/2532952zbMath0825.62819OpenAlexW2060727156WikidataQ52339856 ScholiaQ52339856MaRDI QIDQ4855194
Publication date: 13 December 1995
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2532952
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)
Related Items (12)
A curtailed procedure for selecting among treatments with two Bernoulli endpoints ⋮ Two-stage phase II trials with early stopping for effectiveness and safety as well as ineffectiveness or harm ⋮ Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials ⋮ Some geometric methods for constructing decision criteria based on two-dimensional parame\-ters ⋮ On the maximum total sample size of a group sequential test about bivariate binomial propor\-tions ⋮ Treatment Comparisons Based on Two‐Dimensional Safety and Efficacy Alternatives in Oncology Trials ⋮ Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes ⋮ A Bayesian Group Sequential Approach for Multiple Endpoints ⋮ Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials ⋮ Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials ⋮ Testing Statistical Hypotheses on Stochastic Ordering of Discrete Distributions ⋮ MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION
This page was built for publication: Bivariate Sequential Designs for Phase II Trials
